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CASE REPORT
Granuloma faciale: a rare disease from a 
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INTRODUTION
Granuloma faciale (GF) is a rare and benign
skin disease characterized by chronic leukocytoclastic
vasculitis with dense infiltration of polimorfonuclear-
es.1,2 It is most common in males, typically in middle-
aged white individuals.1 Of unknown origin, it is
characterized by predominantly facial skin lesions
whose course is chronic and slowly progressive.3
Diagnosis is based on clinical features,
histopathology and, more recently, dermatoscopy.1
Multiple modalities of medical and surgical treatment
have been suggested, but none has proved to be con-
sistently effective.4
The following report shows the importance of
including GF in the differential diagnosis of face sar-
coid lesions and analyses its dermoscopic features.
CASE REPORT
Male patient, 40 years old, referred an erythe-
matous-edematous asymptomatic lesion in the right
malar region for 4 years. He denied other skin lesions,
systemic symptoms and comorbidities. He was using
topical steroids (betamethasone dipropionate 0.05%
cream) and prednisone 60 mg / day for 2 months.
Physical examination showed erythematous plaque,
infiltrated, on the right malar region, with prominent
follicular orifices, assuming a “peau d’orange” appear-
ance. (Figure 1).
The dermoscopic examination showed a pink
background, with some areas blackened, white stria-
tions in different directions and prominent follicular
orifices (Figure 2).
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Histopathological examination showed intense
mixed inflammatory infiltrate of micronodular aspect,
composed of lymphocytes, histiocytes, neutrophils
and numerous eosinophils. The described infiltration
had not reached the subepidermal region (Grenz
zone) and there was no evidence of vasculitis (Figure
3). Immunohistochemistry suggested polyclonality
(CD3 +, CD4 +, CD8 +, CD30 +).
GF was diagnosed based on clinical examina-
tion, dermoscopy and histopathological aspects.
Laboratory tests were within normal limits, and ANA
(antinuclear factor), VDRL (Venereal Disease Research
Laboratory) and smear lymph, negatives. Dapsone
was prescribed 100 mg / day. Intralesional corticos-
teroid and prednisone were suspended. The patient
returned after nine months of treatment with partial
improvement (Figure 4).
DISCUSSION
The term GF was originally described by
Wigley in 1945 as eosinophilic granuloma of the skin,
and was further defined by Lever and Leeper Pinkus
a few years later.4
Granuloma faciale has an unknown etiology,
but possible predisposing factors include actinic expo-
sure, radiation, trauma, allergy, or an Arthus-like reac-
tion.5 It prevails between the third and fifth decade,
with chronic course and exacerbation with sun and
heat exposure.2
Clinically, GF manifests as papules, plaques or
nodules, solitary or multiple, with no tendency to
ulceration, whose color varies from red to violet.2,6
Superficial telangiectasias and follicular accentuation
can often be observed, although normally its surface is
smooth.1,4 Our case showed the typical “peau d’orange”
appearance, exemplifying the follicular accentuation.
FIGURE 1: 
Pretreatment.
Erythematous
plaque, infiltra-
ted, on the right
malar region,
with prominent
follicular orifices,
with a "peau
d'orange" aspect
FIGURE 2: Dermoscopy. Pink background with some areas blacke-
ned, white striations in different directions and prominent follicular
orifices
FIGURE 3: 
Histopathology.
Intense mixed
inflammatory
infiltrate of
micronodular
aspect, preser-
ving the subepi-
dermal region
(Grenz zone)
FIGURE 4: 
Post treatment.
Partial improve-
ment on clinical
aspect after nine
months of treat-
ment
Granuloma faciale: a rare disease from a dermoscopy perspective  99
An Bras Dermatol. 2013;88(6 Suppl 1):97-100.
The typical lesion is a solitary plaque on the
face, as presented by our patient. The favored sites are
the sides of the nose (30%), tip of the nose (7%), preau-
ricular area (22%), cheeks (22%), forehead (15%), and
helix of the ear (4%).6
Extrafacial involvement is rare and has been
reported to involve the back, arms, chest, shoulders,
and thigh.6 The lesions are generally asymptomatic,
but some patients report associated burning and itch-
ing.4 GF is not associated with systemic involvement.
The only extracutaneous lesion, whose association
was described with facial granuloma, is eosinophilic
angiocentric fibrosis, which affects the mouth and
upper airways.3
The main clinical differential diagnoses include
erythema elevatum diutinum, sarcoidosis, cutaneous
lymphomas, lymphocytoma cutis, discoid lupus,
basal cell carcinoma, lymphocytic infiltrate of Jessner,
fixed drug eruption, lupus vulgaris, fungal and
mycobacterial infections.1,2,4,6 Despite the appearance
of the skin, GF rarely causes difficulties in the
histopathological differentiation of mycosis fungoides
or other types of lymphomas due to the lack of
involvement of the epidermis and the polyclonal infil-
trate, as shown in our case.1
The only report of GF dermoscopy revealed
translucent whitish-grayish structureless areas, inter-
mingled with orthogonal whitish streaks and the pres-
ence of focused and elongated telangiectasias , similar
to streaks identified in dermoscopy of the described
case; the pink background, with follicular accentua-
tion of the case, does match with the clinical appear-
ance of “peau d’orange”.1 The patient described above
was elderly (72 years) and already had telangiectasias
on the face. Clinically, GF may mimic cutaneous sar-
coidosis, discoid lupus erythematosus and lupus vul-
garis.1 Dermoscopy of these diseases shows similari-
ties in some aspects (Chart 1).1,7-10 Definitive diagnosis
is made by histological examination of the lesion.
Histopathologically, GF is characterized by the
presence of an unaltered epidermis, which is separat-
ed from a zone of dermal inﬂammation by a grenz
zone of uninvolved upper dermis.1,5 There is an
intense infiltration of polymorph below the Grenz
zone consisting of neutrophils, lymphocytes, histio-
cytes, eosinophils and histiocytes.1,5 The adnexal struc-
tures of the skin are spared.1 Vascular inflammation,
including perivascular inflammation with nuclear
dust, and damage in the vessel wall, are frequently
observed, although it was not present in this case.
Erythrocyte extravasation and hemosiderin deposi-
tion were found, which may have contributed to the
color of the  lesion.1
The laboratory evaluation was normal except
for occasional mild blood eosinophilia.3
The disease is known to be notoriously resist-
ant to therapy, although in some cases it can resolve
spontaneously.4 Proposed treatment schemes include
colchicine, dapsone, antimalarials, gold injections, iso-
niazid, clofazimine, associated with psoralen ultravio-
let radiation (PUVA), topical and intralesional corti-
costeroids and, more recently, topical tacrolimus.4 A
variety of surgical procedures such as surgical exci-
sion with or without grafting, dermabrasion, laser
argon, carbon dioxide laser, pulsed dye laser, electro-
surgery and cryotherapy have also been used in the
management of GF with varying results.4,6
The use of topical tacrolimus has recently been
demonstrated as a safe and effective option. This
immunomodulatory agent inactivates calcineurin
leading to blockage of T cell activation and inhibition
of interferon secretion.1
Among the treatments available, we chose dap-
sone and intralesional corticosteroids. Therapeutic
CHART 1: Dermoscopic aspect of GF and its differential diagnoses
Disease Dermoscopic aspects
GF A translucent white-gray background intermingled
with whitish streaks and elongated telangiectasias.1
Cutaneous sarcoidosis Translucent yellow to orange globular-like or structureless areas associated with linear vessels.7
Lupus vulgaris Fine focused telangiectasias on a typical yellow to gold-colored background. In addition, some milia-
like cysts and whitish reticular streaks are observed.8
Discoid lupus erythematosus Erythema, keratin plugs and pigmentary changes are variably present.9
Basal cell carcinoma Different patterns: arborizing telangiectasias, multiple blue-gray globules, large blue-gray ovoid 
nests, leaflike areas, spoke wheel areas and erosion or ulceration.10
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response was partial improvement, consistent with
the data found in the literature.
This case demonstrates the importance of
including GF between the clinical differential diagno-
sis of sarcoid lesions of the face and describes the use-
fulness of dermoscopy as a further tool for identifica-
tion and differentiation. q
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